Accordingly, it has been reported that the therapeutic modulation of Sirt1 ameliorates obesity- and age-related endothelial dysfunction and protects against high-fat diet-induced metabolic abnormalities [119,120]. This evidence concerns the gene SIRT1 and obesity due to melanocortin 4 receptor deficiency.